M&A Deal Summary |
|
|---|---|
| Date | 2021-04-08 |
| Target | Velocity Clinical Research |
| Sector | Life Science |
| Buyer(s) | GHO Capital Partners |
| Sellers(s) | NaviMed Capital |
| Deal Type | Secondary Buyout |
| Advisor(s) | Harris Williams & Co. (Financial) Bass, Berry & Sims (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 2014 |
| PE ASSETS | 6.0B EUR |
| Size | Mega |
| Type | Sector Focused |
GHO Capital Partners is a private investment firm focused on the healthcare sector. The Firm will consider opportunities throughout Europe and seeks well-established, profitable businesses that have the potential to deliver a combination of double-digit top line growth, significant efficiency gains and international expansion. GHO Capital Partners was established in 2014 and is based in London, England.
| DEAL STATS | # |
|---|---|
| Overall | 14 of 20 |
| Sector (Life Science) | 11 of 14 |
| Type (Secondary Buyout) | 7 of 11 |
| State (North Carolina) | 2 of 3 |
| Country (United States) | 5 of 9 |
| Year (2021) | 1 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-06-03 |
X-Chem
Waltham, Massachusetts, United States X-Chem is a biotechnology company that is a provider of DNA-Encoded Library (DEL)-based discovery services. DEL technology, allowing customers to screen billions of compounds simultaneously against a single biological target, is an innovative and high growth segment of the market as pharmaceutical companies look for access to cutting edge scientific expertise to support an increasingly challenging drug discovery process. X-Chem has established partnerships with AbbVie, Alexion, Almirall, Bristol-Myers Squibb, AstraZeneca, Bayer, Department of Defense/Harvard, Gilead, Janssen, Maruho, MD Anderson Cancer Center, Ono, Otsuka, Pfizer, Roche, Sanofi, Taiho Pharma, Vertex, and several other leading pharmaceutical companies, biotechnology organizations, and academic centers. X-Chem was founded in 2009 and is based in Waltham, Massachusetts. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-06-28 |
DNA Diagnostics Center
Fairfield, Ohio, United States DNA Diagnostics Center is a provider of private DNA testing services for paternity and other family relationships, forensics, cell line authentication, and ancestry. DDC provides products approved by the FDA and EMA, and is accredited by the American Association of Blood Banks (AABB), The Ministry of Justice, The College of American Pathologists (CAP), and The Clinical Laboratory Improvement Amendment (CLIA). DNA Diagnostics Center was founded in 1995 and is based in Fairfield, Ohio. |
Sell | - |
NaviMed Capital is a private equity firm focused exclusively on investments in the healthcare sector. NaviMed seeks North American headquartered businesses with strong organic and inorganic opportunities for growth. The Firm will consider both control and minority positions looks to commit $5 to $30 million of equity capital per transaction. NaviMed Capital was established in 2011 and is based in Rosslyn, Virginia.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector (Life Science) | 1 of 1 |
| Type (Secondary Buyout) | 1 of 1 |
| State (North Carolina) | 1 of 1 |
| Country (United States) | 1 of 2 |
| Year (2021) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-01-01 |
OPN Healthcare
Glendale, California, United States OPN healthcare is a management services organization providing delegated risk contracting services between healthcare payors and a network of community oncologists. OPN Healthcare was founded in 1999 and is based in Glendale, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-01-01 |
ClariMed
Chadds Ford, Pennsylvania, United States ClariMed is a human-centered development and regulatory practice for medical products developed by Pharmaceutical and Medical device manufacturers. ClariMed is based in Chadds Ford, Pennsylvania. |
Buy | - |
